Cas:91419-49-7 1-Boc-3-Carbamoylpiperidine manufacturer & supplier

Chemical Name:1-Boc-3-Carbamoylpiperidine

CAS.NO:91419-49-7

Synonyms:2-Methyl-2-propanyl 3-carbamoyl-1-piperidinecarboxylate;tert-butyl 3-carbamoylpiperidine-1-carboxylate;1-Piperidinecarboxylic acid, 3-(aminocarbonyl)-, 1,1-dimethylethyl ester

Molecular Formula:C₁₁H₂₀N₂O₃

Molecular Weight:228.288

HS Code:2933399090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:384.4±31.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.498

PSA:72.63000

Exact Mass:228.147400

LogP:0.14

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Methyl-2-propanyl 3-carbamoyl-1-piperidinecarboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Piperidinecarboxylic acid, 3-(aminocarbonyl)-, 1,1-dimethylethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Methyl-2-propanyl 3-carbamoyl-1-piperidinecarboxylate Use and application,2-Methyl-2-propanyl 3-carbamoyl-1-piperidinecarboxylate technical grade,usp/ep/jp grade.

Related News: A November 2020 analysis by researchers at the University of Oxford found Innova’s tests could be more or less accurate depending on who was using them—ranging from lab scientists to trained healthcare professionals to the general public—but determined the tests overall had a low failure rate and high specificity, despite some variations seen in production batches. Still, Innova’s test and antigen diagnostics more broadly have been seen as less accurate compared to gold-standard, lab-based PCR screening. 1-Boc-3-Carbamoylpiperidine manufacturer Beta Bionics is a for-profit Massachusetts public benefit corporation founded in 2015 to commercialize the iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia. 1-Boc-3-Carbamoylpiperidine supplier In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired. 1-Boc-3-Carbamoylpiperidine vendor Lilly has pledged to address the problems, and said none of them affected drugs in the market. The FDA, which has taken no public action, did not respond to requests for comment. 1-Boc-3-Carbamoylpiperidine factory A November 2020 analysis by researchers at the University of Oxford found Innova’s tests could be more or less accurate depending on who was using them—ranging from lab scientists to trained healthcare professionals to the general public—but determined the tests overall had a low failure rate and high specificity, despite some variations seen in production batches. Still, Innova’s test and antigen diagnostics more broadly have been seen as less accurate compared to gold-standard, lab-based PCR screening.